A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Clinical trial NCT01340053 · COMPLETED
Trial details
- NCT number
- NCT01340053
- Sponsor
- Ardelyx
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.